RAMAT GAN, ISRAEL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) ...

RAMAT GAN, ISRAEL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced that it is working diligently to close the acquisition ...

The Bowflex T6, T9, and T16 share the same smooth MaxReact motor and plush, joint-friendly FlexZone cushioning—ideal for real-world home workouts. The T16 is the star: a powerhouse with a cinematic ...

Beyond Air (NASDAQ: XAIR), majority owner of NeuroNOS, to hold 19.99% of XTL's post-transaction share capital Beyond Air to receive up to $32.5 million in upfront, development and commercial milestone ...

The consideration includes 19.9% of XTL's issued shares, $1 million in cash, and milestone-based contingent payments of up to $32.5 million. The transaction remains subject to customary closing ...

(RTTNews) - XTL Biopharmaceuticals Ltd. (XTLB), a biopharmaceutical company, Tuesday announced that it has agreed to acquire 85 percent of NeuroNOS Ltd., a subsidiary of Beyond Air, Inc. (XAIR), a ...

State Street® SPDR® S&P® Telecom ETF is upgraded to Buy for 2026, reflecting its evolution into a growth-focused, small/mid-cap telecom and AI infrastructure portfolio. XTL’s 2025 total return neared ...

The latest update is out from XTL Biopharmaceuticals Sponsored ADR ( (XTLB)). On December 24, 2025, XTL Biopharmaceuticals announced it had received a Nasdaq notification, dated December 22, 2025, ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Welcome to “Today in Gear,” your daily snapshot of the most important releases in style, watches, tech, motoring, fitness, home and the outdoors. Today in Gear: The most important news in the product ...